

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 4.74839253 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.74839253 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 4.48164371 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.48164371 |
| 5 | ethanol oxidation (GO:0006069) | 4.06513563 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 3.98596964 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 3.91824407 |
| 8 | gamma-aminobutyric acid transport (GO:0015812) | 3.85651195 |
| 9 | creatine metabolic process (GO:0006600) | 3.84237569 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 3.82130246 |
| 11 | positive regulation of synapse maturation (GO:0090129) | 3.78036119 |
| 12 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.77949251 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.77397048 |
| 14 | synaptic vesicle maturation (GO:0016188) | 3.70134183 |
| 15 | * glutamate metabolic process (GO:0006536) | 3.69620458 |
| 16 | cellular ketone body metabolic process (GO:0046950) | 3.68466379 |
| 17 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.68058773 |
| 18 | bile acid biosynthetic process (GO:0006699) | 3.66263368 |
| 19 | potassium ion import (GO:0010107) | 3.61066293 |
| 20 | locomotory exploration behavior (GO:0035641) | 3.60625719 |
| 21 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.52390345 |
| 22 | neuronal action potential propagation (GO:0019227) | 3.52043194 |
| 23 | kynurenine metabolic process (GO:0070189) | 3.52027618 |
| 24 | glyoxylate metabolic process (GO:0046487) | 3.49237107 |
| 25 | lysine metabolic process (GO:0006553) | 3.44399596 |
| 26 | lysine catabolic process (GO:0006554) | 3.44399596 |
| 27 | dicarboxylic acid catabolic process (GO:0043649) | 3.42456609 |
| 28 | omega-hydroxylase P450 pathway (GO:0097267) | 3.41077019 |
| 29 | glutamate secretion (GO:0014047) | 3.36784804 |
| 30 | cysteine metabolic process (GO:0006534) | 3.36533998 |
| 31 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.36245931 |
| 32 | postsynaptic membrane organization (GO:0001941) | 3.33050650 |
| 33 | indole-containing compound catabolic process (GO:0042436) | 3.32696750 |
| 34 | indolalkylamine catabolic process (GO:0046218) | 3.32696750 |
| 35 | tryptophan catabolic process (GO:0006569) | 3.32696750 |
| 36 | vocalization behavior (GO:0071625) | 3.31642392 |
| 37 | cerebellar granule cell differentiation (GO:0021707) | 3.23070833 |
| 38 | high-density lipoprotein particle remodeling (GO:0034375) | 3.22941569 |
| 39 | * neurotransmitter secretion (GO:0007269) | 3.21334487 |
| 40 | urea metabolic process (GO:0019627) | 3.21125564 |
| 41 | urea cycle (GO:0000050) | 3.21125564 |
| 42 | aspartate family amino acid catabolic process (GO:0009068) | 3.20964988 |
| 43 | L-amino acid import (GO:0043092) | 3.19912459 |
| 44 | sulfur amino acid catabolic process (GO:0000098) | 3.19148491 |
| 45 | synaptic vesicle exocytosis (GO:0016079) | 3.17981037 |
| 46 | ketone body metabolic process (GO:1902224) | 3.17358448 |
| 47 | blood coagulation, intrinsic pathway (GO:0007597) | 3.15771744 |
| 48 | C4-dicarboxylate transport (GO:0015740) | 3.15227411 |
| 49 | bile acid metabolic process (GO:0008206) | 3.12989537 |
| 50 | neurotransmitter uptake (GO:0001504) | 3.11950979 |
| 51 | cellular sodium ion homeostasis (GO:0006883) | 3.10660113 |
| 52 | regulation of synapse maturation (GO:0090128) | 3.10241405 |
| 53 | tryptophan metabolic process (GO:0006568) | 3.09398459 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 3.08593729 |
| 55 | ethanol metabolic process (GO:0006067) | 3.08239600 |
| 56 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.07787962 |
| 57 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.07164627 |
| 58 | cellular modified amino acid catabolic process (GO:0042219) | 3.04411979 |
| 59 | potassium ion homeostasis (GO:0055075) | 2.97674261 |
| 60 | drug catabolic process (GO:0042737) | 2.97226238 |
| 61 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.96269599 |
| 62 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.95764704 |
| 63 | nitrogen cycle metabolic process (GO:0071941) | 2.94734025 |
| 64 | * cellular amino acid catabolic process (GO:0009063) | 2.94154378 |
| 65 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.93882316 |
| 66 | coenzyme catabolic process (GO:0009109) | 2.93816505 |
| 67 | NADH metabolic process (GO:0006734) | 2.93785363 |
| 68 | serine family amino acid catabolic process (GO:0009071) | 2.93039532 |
| 69 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.92226268 |
| 70 | reverse cholesterol transport (GO:0043691) | 2.91068785 |
| 71 | cellular potassium ion homeostasis (GO:0030007) | 2.90540014 |
| 72 | negative regulation of fibrinolysis (GO:0051918) | 2.89906187 |
| 73 | oxaloacetate metabolic process (GO:0006107) | 2.88586127 |
| 74 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.87585710 |
| 75 | aromatic amino acid family metabolic process (GO:0009072) | 2.87549470 |
| 76 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.86809177 |
| 77 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.86640926 |
| 78 | sodium ion export (GO:0071436) | 2.84918427 |
| 79 | oxidative demethylation (GO:0070989) | 2.83002708 |
| 80 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.82101934 |
| 81 | tyrosine metabolic process (GO:0006570) | 2.82094295 |
| 82 | plasma lipoprotein particle remodeling (GO:0034369) | 2.81841568 |
| 83 | protein-lipid complex remodeling (GO:0034368) | 2.81841568 |
| 84 | macromolecular complex remodeling (GO:0034367) | 2.81841568 |
| 85 | regulation of fibrinolysis (GO:0051917) | 2.79900032 |
| 86 | layer formation in cerebral cortex (GO:0021819) | 2.77396290 |
| 87 | homocysteine metabolic process (GO:0050667) | 2.77360228 |
| 88 | amino-acid betaine metabolic process (GO:0006577) | 2.75593314 |
| 89 | central nervous system myelination (GO:0022010) | 2.75518689 |
| 90 | axon ensheathment in central nervous system (GO:0032291) | 2.75518689 |
| 91 | protein localization to synapse (GO:0035418) | 2.75201637 |
| 92 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.74748859 |
| 93 | protein carboxylation (GO:0018214) | 2.74748859 |
| 94 | regulation of cholesterol esterification (GO:0010872) | 2.74719013 |
| 95 | regulation of protein activation cascade (GO:2000257) | 2.74099201 |
| 96 | complement activation, alternative pathway (GO:0006957) | 2.73867095 |
| 97 | membrane depolarization during action potential (GO:0086010) | 2.72958076 |
| 98 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.71989437 |
| 99 | amino acid import (GO:0043090) | 2.71515035 |
| 100 | regulation of triglyceride catabolic process (GO:0010896) | 2.71457276 |
| 101 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.71219684 |
| 102 | exogenous drug catabolic process (GO:0042738) | 2.70873318 |
| 103 | drug metabolic process (GO:0017144) | 2.70831030 |
| 104 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.70555597 |
| 105 | response to mercury ion (GO:0046689) | 2.69757077 |
| 106 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.69748915 |
| 107 | 2-oxoglutarate metabolic process (GO:0006103) | 2.69267164 |
| 108 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.68657829 |
| 109 | cell communication by electrical coupling (GO:0010644) | 2.68635442 |
| 110 | regulation of synapse structural plasticity (GO:0051823) | 2.68095553 |
| 111 | triglyceride homeostasis (GO:0070328) | 2.67444726 |
| 112 | acylglycerol homeostasis (GO:0055090) | 2.67444726 |
| 113 | acetyl-CoA metabolic process (GO:0006084) | 2.67207337 |
| 114 | synaptic transmission, glutamatergic (GO:0035249) | 2.67170144 |
| 115 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.66343947 |
| 116 | detection of calcium ion (GO:0005513) | 2.65849157 |
| 117 | * short-chain fatty acid metabolic process (GO:0046459) | 2.65426083 |
| 118 | glycine metabolic process (GO:0006544) | 2.63868628 |
| 119 | exploration behavior (GO:0035640) | 2.63831676 |
| 120 | glutamine family amino acid catabolic process (GO:0009065) | 2.62902713 |
| 121 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.62768565 |
| 122 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.62526934 |
| 123 | cellular glucuronidation (GO:0052695) | 2.62264394 |
| 124 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.61837928 |
| 125 | negative regulation of cholesterol transport (GO:0032375) | 2.61343507 |
| 126 | negative regulation of sterol transport (GO:0032372) | 2.61343507 |
| 127 | regulation of synaptic vesicle transport (GO:1902803) | 2.61017927 |
| 128 | presynaptic membrane assembly (GO:0097105) | 2.60827270 |
| 129 | fructose metabolic process (GO:0006000) | 2.60764151 |
| 130 | skeletal muscle contraction (GO:0003009) | 2.60567043 |
| 131 | * neurotransmitter transport (GO:0006836) | 2.60439188 |
| 132 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.59878730 |
| 133 | neuromuscular process controlling posture (GO:0050884) | 2.58710488 |
| 134 | * regulation of neurotransmitter levels (GO:0001505) | 2.57946110 |
| 135 | activation of protein kinase A activity (GO:0034199) | 2.57263895 |
| 136 | alanine transport (GO:0032328) | 2.57180785 |
| 137 | regulation of bile acid biosynthetic process (GO:0070857) | 2.56202493 |
| 138 | proline transport (GO:0015824) | 2.53945802 |
| 139 | regulation of complement activation (GO:0030449) | 2.52934480 |
| 140 | neuron cell-cell adhesion (GO:0007158) | 2.52605419 |
| 141 | regulation of cholesterol homeostasis (GO:2000188) | 2.51842340 |
| 142 | * organic acid catabolic process (GO:0016054) | 2.49967770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.78123834 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.91263972 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.37236721 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.79110710 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.69411834 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.59689976 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.53668981 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.41482602 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.40259699 |
| 10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.30059982 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.21439059 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.19676090 |
| 13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.18375253 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.09915379 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.09157013 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.08059847 |
| 17 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.05168519 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.04130398 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.04130398 |
| 20 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.03537599 |
| 21 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.02895250 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.01409287 |
| 23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.99684001 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.91724163 |
| 25 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.87963760 |
| 26 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.87330682 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.85876166 |
| 28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.85069831 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.82943215 |
| 30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.78772055 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.75363346 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.72997776 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.72411810 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.69165637 |
| 35 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.68929571 |
| 36 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.66401854 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.65535293 |
| 38 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.64454208 |
| 39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.50916452 |
| 40 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.49211723 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.47922863 |
| 42 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.47142984 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.42900226 |
| 44 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.40449937 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39335079 |
| 46 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.30962580 |
| 47 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29119080 |
| 48 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.28828974 |
| 49 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27498045 |
| 50 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.24530389 |
| 51 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.24433041 |
| 52 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.22872067 |
| 53 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.22867767 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20166596 |
| 55 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.17720580 |
| 56 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.16712313 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16233030 |
| 58 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15250587 |
| 59 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.14029718 |
| 60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12038370 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11962365 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10584161 |
| 63 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.10221282 |
| 64 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09747256 |
| 65 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.09512970 |
| 66 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.08129470 |
| 67 | * AR_19668381_ChIP-Seq_PC3_Human | 1.07934854 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07118010 |
| 69 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05861414 |
| 70 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.05781358 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05538979 |
| 72 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04854827 |
| 73 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01556423 |
| 74 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01346300 |
| 75 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.01324503 |
| 76 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99920230 |
| 77 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99754446 |
| 78 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.98925262 |
| 79 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98008666 |
| 80 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97543170 |
| 81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97391579 |
| 82 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97075439 |
| 83 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97058097 |
| 84 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97025683 |
| 85 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95170778 |
| 86 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.94557739 |
| 87 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.94308225 |
| 88 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.93370616 |
| 89 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.93210796 |
| 90 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.92744410 |
| 91 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.91943004 |
| 92 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91465419 |
| 93 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.91145613 |
| 94 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89213571 |
| 95 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86787911 |
| 96 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86754766 |
| 97 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.86384131 |
| 98 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85802149 |
| 99 | KDM2B_26808549_Chip-Seq_K562_Human | 0.84441054 |
| 100 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.84241423 |
| 101 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84088131 |
| 102 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.83906133 |
| 103 | TCF4_23295773_ChIP-Seq_U87_Human | 0.83845309 |
| 104 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83811104 |
| 105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.82964698 |
| 106 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.82336240 |
| 107 | MYC_22102868_ChIP-Seq_BL_Human | 0.82025545 |
| 108 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80833152 |
| 109 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.80544188 |
| 110 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.80510313 |
| 111 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.80500750 |
| 112 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.80467791 |
| 113 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.80009834 |
| 114 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.79578238 |
| 115 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.78665278 |
| 116 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.78403870 |
| 117 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77909739 |
| 118 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77909739 |
| 119 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.77788374 |
| 120 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.77733652 |
| 121 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.77490904 |
| 122 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.77020530 |
| 123 | RXR_22108803_ChIP-Seq_LS180_Human | 0.76841056 |
| 124 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.75709820 |
| 125 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.75235213 |
| 126 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.73501877 |
| 127 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.73335731 |
| 128 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73079085 |
| 129 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.72993578 |
| 130 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.72968284 |
| 131 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.72081671 |
| 132 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71572900 |
| 133 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.71549415 |
| 134 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.69664343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.99409960 |
| 2 | MP0005360_urolithiasis | 4.43695958 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.15861576 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.92154123 |
| 5 | MP0005365_abnormal_bile_salt | 3.65218355 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.13991079 |
| 7 | MP0002822_catalepsy | 2.92118710 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 2.76386301 |
| 9 | MP0003880_abnormal_central_pattern | 2.70979231 |
| 10 | MP0004270_analgesia | 2.45951682 |
| 11 | MP0009745_abnormal_behavioral_response | 2.35389785 |
| 12 | MP0003252_abnormal_bile_duct | 2.28706331 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.28171189 |
| 14 | MP0004145_abnormal_muscle_electrophysio | 2.25251423 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.19257146 |
| 16 | * MP0002064_seizures | 2.18298813 |
| 17 | * MP0009046_muscle_twitch | 1.93263146 |
| 18 | MP0003329_amyloid_beta_deposits | 1.93231669 |
| 19 | MP0003195_calcinosis | 1.90941174 |
| 20 | * MP0005332_abnormal_amino_acid | 1.89514180 |
| 21 | MP0001486_abnormal_startle_reflex | 1.85651235 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.84845170 |
| 23 | MP0002572_abnormal_emotion/affect_behav | 1.83991851 |
| 24 | MP0005423_abnormal_somatic_nervous | 1.80325145 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.76508136 |
| 26 | MP0003787_abnormal_imprinting | 1.74750674 |
| 27 | MP0005083_abnormal_biliary_tract | 1.73488874 |
| 28 | MP0001986_abnormal_taste_sensitivity | 1.72805739 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 1.72451860 |
| 30 | * MP0002272_abnormal_nervous_system | 1.71558719 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.66165044 |
| 32 | MP0001968_abnormal_touch/_nociception | 1.58967520 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.56178952 |
| 34 | MP0002734_abnormal_mechanical_nocicepti | 1.55104545 |
| 35 | MP0003690_abnormal_glial_cell | 1.54397162 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.52788061 |
| 37 | MP0004885_abnormal_endolymph | 1.52470095 |
| 38 | MP0004147_increased_porphyrin_level | 1.51926035 |
| 39 | MP0001666_abnormal_nutrient_absorption | 1.50933801 |
| 40 | MP0002118_abnormal_lipid_homeostasis | 1.50554257 |
| 41 | MP0004043_abnormal_pH_regulation | 1.41486649 |
| 42 | MP0001440_abnormal_grooming_behavior | 1.40631916 |
| 43 | MP0009840_abnormal_foam_cell | 1.35087689 |
| 44 | MP0004924_abnormal_behavior | 1.32933022 |
| 45 | MP0005386_behavior/neurological_phenoty | 1.32933022 |
| 46 | MP0002638_abnormal_pupillary_reflex | 1.32039018 |
| 47 | MP0000747_muscle_weakness | 1.31898655 |
| 48 | MP0005535_abnormal_body_temperature | 1.30638061 |
| 49 | MP0004130_abnormal_muscle_cell | 1.28693129 |
| 50 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.25170291 |
| 51 | MP0002067_abnormal_sensory_capabilities | 1.24931202 |
| 52 | MP0003868_abnormal_feces_composition | 1.23555130 |
| 53 | MP0002733_abnormal_thermal_nociception | 1.22192005 |
| 54 | MP0000604_amyloidosis | 1.21554283 |
| 55 | MP0003633_abnormal_nervous_system | 1.18687001 |
| 56 | MP0001984_abnormal_olfaction | 1.15194889 |
| 57 | MP0000749_muscle_degeneration | 1.14493502 |
| 58 | MP0008569_lethality_at_weaning | 1.13434303 |
| 59 | MP0002557_abnormal_social/conspecific_i | 1.13076066 |
| 60 | MP0002332_abnormal_exercise_endurance | 1.12816305 |
| 61 | MP0004019_abnormal_vitamin_homeostasis | 1.12125806 |
| 62 | MP0004036_abnormal_muscle_relaxation | 1.11979719 |
| 63 | MP0004858_abnormal_nervous_system | 1.10150300 |
| 64 | MP0004142_abnormal_muscle_tone | 1.09361184 |
| 65 | MP0002269_muscular_atrophy | 1.09193747 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 1.07686558 |
| 67 | MP0002736_abnormal_nociception_after | 1.06043832 |
| 68 | MP0002106_abnormal_muscle_physiology | 1.04846492 |
| 69 | MP0003123_paternal_imprinting | 1.04321206 |
| 70 | MP0002009_preneoplasia | 1.03890428 |
| 71 | MP0008872_abnormal_physiological_respon | 1.02779813 |
| 72 | MP0001970_abnormal_pain_threshold | 1.02150517 |
| 73 | MP0006276_abnormal_autonomic_nervous | 1.02104915 |
| 74 | MP0000955_abnormal_spinal_cord | 1.01131045 |
| 75 | * MP0002066_abnormal_motor_capabilities/c | 0.99894510 |
| 76 | MP0008874_decreased_physiological_sensi | 0.98430209 |
| 77 | MP0004811_abnormal_neuron_physiology | 0.97435914 |
| 78 | MP0003631_nervous_system_phenotype | 0.96802482 |
| 79 | MP0005670_abnormal_white_adipose | 0.96795913 |
| 80 | MP0001661_extended_life_span | 0.96319353 |
| 81 | MP0003121_genomic_imprinting | 0.95887692 |
| 82 | MP0003879_abnormal_hair_cell | 0.93471391 |
| 83 | MP0000609_abnormal_liver_physiology | 0.93253390 |
| 84 | MP0000778_abnormal_nervous_system | 0.92996812 |
| 85 | MP0002735_abnormal_chemical_nociception | 0.92677362 |
| 86 | MP0002078_abnormal_glucose_homeostasis | 0.92439513 |
| 87 | MP0004215_abnormal_myocardial_fiber | 0.92071673 |
| 88 | MP0000566_synostosis | 0.91345149 |
| 89 | MP0001502_abnormal_circadian_rhythm | 0.90955252 |
| 90 | MP0004087_abnormal_muscle_fiber | 0.89314532 |
| 91 | MP0002090_abnormal_vision | 0.87586494 |
| 92 | MP0002184_abnormal_innervation | 0.87502077 |
| 93 | MP0000569_abnormal_digit_pigmentation | 0.87021217 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.86734644 |
| 95 | MP0002069_abnormal_eating/drinking_beha | 0.86370712 |
| 96 | MP0002229_neurodegeneration | 0.86158570 |
| 97 | MP0008961_abnormal_basal_metabolism | 0.86006262 |
| 98 | MP0000751_myopathy | 0.85918126 |
| 99 | MP0003075_altered_response_to | 0.84607124 |
| 100 | MP0003137_abnormal_impulse_conducting | 0.83832909 |
| 101 | MP0004085_abnormal_heartbeat | 0.83457924 |
| 102 | MP0002876_abnormal_thyroid_physiology | 0.82893547 |
| 103 | MP0002882_abnormal_neuron_morphology | 0.82843714 |
| 104 | MP0005451_abnormal_body_composition | 0.82347708 |
| 105 | MP0008877_abnormal_DNA_methylation | 0.81779640 |
| 106 | MP0001529_abnormal_vocalization | 0.81411670 |
| 107 | MP0005551_abnormal_eye_electrophysiolog | 0.80676496 |
| 108 | MP0002138_abnormal_hepatobiliary_system | 0.80405355 |
| 109 | MP0000013_abnormal_adipose_tissue | 0.79631544 |
| 110 | MP0000920_abnormal_myelination | 0.79411799 |
| 111 | MP0005369_muscle_phenotype | 0.78583472 |
| 112 | MP0003632_abnormal_nervous_system | 0.78513158 |
| 113 | MP0001177_atelectasis | 0.75772616 |
| 114 | MP0004742_abnormal_vestibular_system | 0.75275233 |
| 115 | MP0003191_abnormal_cellular_cholesterol | 0.73964429 |
| 116 | MP0005187_abnormal_penis_morphology | 0.73665238 |
| 117 | MP0003646_muscle_fatigue | 0.71096087 |
| 118 | MP0005167_abnormal_blood-brain_barrier | 0.70978004 |
| 119 | MP0005645_abnormal_hypothalamus_physiol | 0.69651676 |
| 120 | MP0006036_abnormal_mitochondrial_physio | 0.68768416 |
| 121 | MP0003122_maternal_imprinting | 0.68726508 |
| 122 | MP0005448_abnormal_energy_balance | 0.68373883 |
| 123 | MP0006035_abnormal_mitochondrial_morpho | 0.65466710 |
| 124 | MP0003953_abnormal_hormone_level | 0.65264299 |
| 125 | MP0002971_abnormal_brown_adipose | 0.64990818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.72030497 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.63384870 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.40008902 |
| 4 | Myokymia (HP:0002411) | 4.28458076 |
| 5 | Focal motor seizures (HP:0011153) | 4.22588668 |
| 6 | Exercise-induced myalgia (HP:0003738) | 4.16602925 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 3.92618588 |
| 8 | Xanthomatosis (HP:0000991) | 3.84246837 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 3.68034037 |
| 10 | Nemaline bodies (HP:0003798) | 3.64704925 |
| 11 | Ketosis (HP:0001946) | 3.61737712 |
| 12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.58036787 |
| 13 | Exercise-induced muscle cramps (HP:0003710) | 3.58024903 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.57937528 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 3.53674649 |
| 16 | Prolonged partial thromboplastin time (HP:0003645) | 3.42385654 |
| 17 | Hyperglycinemia (HP:0002154) | 3.32857323 |
| 18 | Ketoacidosis (HP:0001993) | 3.31090065 |
| 19 | Hyperammonemia (HP:0001987) | 3.30702985 |
| 20 | Focal seizures (HP:0007359) | 3.22389279 |
| 21 | Visual hallucinations (HP:0002367) | 3.17637470 |
| 22 | Hyperventilation (HP:0002883) | 3.10651257 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.07381878 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.07381878 |
| 25 | Hyperglycinuria (HP:0003108) | 3.02488576 |
| 26 | Complement deficiency (HP:0004431) | 2.93899242 |
| 27 | Hypoglycemic coma (HP:0001325) | 2.88472202 |
| 28 | Epidermoid cyst (HP:0200040) | 2.88379805 |
| 29 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.81800428 |
| 30 | Hypolipoproteinemia (HP:0010981) | 2.77263055 |
| 31 | Myoglobinuria (HP:0002913) | 2.74985375 |
| 32 | Action tremor (HP:0002345) | 2.74935637 |
| 33 | Subaortic stenosis (HP:0001682) | 2.73254002 |
| 34 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.73254002 |
| 35 | Delayed CNS myelination (HP:0002188) | 2.68125586 |
| 36 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.64885611 |
| 37 | Limb dystonia (HP:0002451) | 2.61037610 |
| 38 | Gout (HP:0001997) | 2.60429616 |
| 39 | Neurofibrillary tangles (HP:0002185) | 2.60255123 |
| 40 | Hypoalphalipoproteinemia (HP:0003233) | 2.60066978 |
| 41 | Dysdiadochokinesis (HP:0002075) | 2.59756299 |
| 42 | Pheochromocytoma (HP:0002666) | 2.56086713 |
| 43 | Calf muscle hypertrophy (HP:0008981) | 2.55475399 |
| 44 | Abnormal social behavior (HP:0012433) | 2.54068756 |
| 45 | Impaired social interactions (HP:0000735) | 2.54068756 |
| 46 | * Status epilepticus (HP:0002133) | 2.53557110 |
| 47 | Epileptic encephalopathy (HP:0200134) | 2.52930574 |
| 48 | Rhabdomyolysis (HP:0003201) | 2.52085438 |
| 49 | EMG: myopathic abnormalities (HP:0003458) | 2.50429695 |
| 50 | Hyporeflexia of lower limbs (HP:0002600) | 2.48697199 |
| 51 | Progressive cerebellar ataxia (HP:0002073) | 2.48518488 |
| 52 | Torticollis (HP:0000473) | 2.48085179 |
| 53 | Intention tremor (HP:0002080) | 2.47749242 |
| 54 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.46241788 |
| 55 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.45885062 |
| 56 | Postural instability (HP:0002172) | 2.45613311 |
| 57 | Cerebral inclusion bodies (HP:0100314) | 2.43678625 |
| 58 | Bundle branch block (HP:0011710) | 2.42213367 |
| 59 | * Generalized tonic-clonic seizures (HP:0002069) | 2.42150710 |
| 60 | Rimmed vacuoles (HP:0003805) | 2.39549790 |
| 61 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.38640376 |
| 62 | Poor eye contact (HP:0000817) | 2.37746683 |
| 63 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.37645852 |
| 64 | Abnormality of the common coagulation pathway (HP:0010990) | 2.37634093 |
| 65 | Abnormality of the lower motor neuron (HP:0002366) | 2.36675861 |
| 66 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.34977091 |
| 67 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.34977091 |
| 68 | Focal dystonia (HP:0004373) | 2.34825210 |
| 69 | Atonic seizures (HP:0010819) | 2.32745750 |
| 70 | Supranuclear gaze palsy (HP:0000605) | 2.31874856 |
| 71 | Urinary urgency (HP:0000012) | 2.31331757 |
| 72 | Depression (HP:0000716) | 2.28083832 |
| 73 | Craniofacial dystonia (HP:0012179) | 2.27986127 |
| 74 | Abnormality of glycolysis (HP:0004366) | 2.27265936 |
| 75 | Dysmetria (HP:0001310) | 2.25396300 |
| 76 | Fetal akinesia sequence (HP:0001989) | 2.25196849 |
| 77 | EMG: neuropathic changes (HP:0003445) | 2.24678109 |
| 78 | Fat malabsorption (HP:0002630) | 2.24058690 |
| 79 | Conjugated hyperbilirubinemia (HP:0002908) | 2.21693837 |
| 80 | Abnormality of methionine metabolism (HP:0010901) | 2.21186022 |
| 81 | Sensorimotor neuropathy (HP:0007141) | 2.20217355 |
| 82 | Skin nodule (HP:0200036) | 2.19673523 |
| 83 | * Anxiety (HP:0000739) | 2.19223151 |
| 84 | Tetraplegia (HP:0002445) | 2.18457214 |
| 85 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.16910139 |
| 86 | Hypoglycemic seizures (HP:0002173) | 2.16473938 |
| 87 | Sudden death (HP:0001699) | 2.14357859 |
| 88 | Abnormality of binocular vision (HP:0011514) | 2.13535356 |
| 89 | Diplopia (HP:0000651) | 2.13535356 |
| 90 | Neonatal onset (HP:0003623) | 2.13064185 |
| 91 | Neuroendocrine neoplasm (HP:0100634) | 2.11593926 |
| 92 | Increased serum pyruvate (HP:0003542) | 2.11180099 |
| 93 | Abnormal eating behavior (HP:0100738) | 2.11089606 |
| 94 | Scanning speech (HP:0002168) | 2.08695013 |
| 95 | Cholecystitis (HP:0001082) | 2.08070399 |
| 96 | Abnormal gallbladder physiology (HP:0012438) | 2.08070399 |
| 97 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.07043222 |
| 98 | Hemiplegia (HP:0002301) | 2.04950333 |
| 99 | Hypercholesterolemia (HP:0003124) | 2.04370879 |
| 100 | EEG with generalized epileptiform discharges (HP:0011198) | 2.04149535 |
| 101 | Hypsarrhythmia (HP:0002521) | 2.04115742 |
| 102 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.03963164 |
| 103 | Hemiparesis (HP:0001269) | 2.03654777 |
| 104 | Spontaneous abortion (HP:0005268) | 2.02887699 |
| 105 | Joint hemorrhage (HP:0005261) | 2.02524702 |
| 106 | Metabolic acidosis (HP:0001942) | 2.02420839 |
| 107 | Myopathic facies (HP:0002058) | 2.01806093 |
| 108 | Epileptiform EEG discharges (HP:0011182) | 2.01719122 |
| 109 | * Absence seizures (HP:0002121) | 2.00647035 |
| 110 | Ankle clonus (HP:0011448) | 2.00389796 |
| 111 | * Dialeptic seizures (HP:0011146) | 1.99341083 |
| 112 | Febrile seizures (HP:0002373) | 1.98996727 |
| 113 | Hyperbilirubinemia (HP:0002904) | 1.98807341 |
| 114 | Spastic gait (HP:0002064) | 1.98501646 |
| 115 | Heart block (HP:0012722) | 1.98215158 |
| 116 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.97678888 |
| 117 | Abnormality of serum amino acid levels (HP:0003112) | 1.96888311 |
| 118 | Abnormality of complement system (HP:0005339) | 1.95226653 |
| 119 | Ventricular fibrillation (HP:0001663) | 1.95171780 |
| 120 | Dysmetric saccades (HP:0000641) | 1.91869762 |
| 121 | Abnormality of the intrinsic pathway (HP:0010989) | 1.91571691 |
| 122 | Confusion (HP:0001289) | 1.90982745 |
| 123 | Abnormal gallbladder morphology (HP:0012437) | 1.89570297 |
| 124 | Fair hair (HP:0002286) | 1.86882178 |
| 125 | Cholelithiasis (HP:0001081) | 1.86426152 |
| 126 | Turricephaly (HP:0000262) | 1.85075264 |
| 127 | Increased circulating renin level (HP:0000848) | 1.83912243 |
| 128 | Impaired vibratory sensation (HP:0002495) | 1.83612051 |
| 129 | Glomerulonephritis (HP:0000099) | 1.83120255 |
| 130 | Abnormality of the corticospinal tract (HP:0002492) | 1.82858754 |
| 131 | Irritability (HP:0000737) | 1.82692331 |
| 132 | Lethargy (HP:0001254) | 1.82454880 |
| 133 | Atrioventricular block (HP:0001678) | 1.81708724 |
| 134 | Cerebral edema (HP:0002181) | 1.81057671 |
| 135 | Agitation (HP:0000713) | 1.80936226 |
| 136 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.80818273 |
| 137 | Lower limb muscle weakness (HP:0007340) | 1.77755292 |
| 138 | Difficulty running (HP:0009046) | 1.77689520 |
| 139 | Hyperkalemia (HP:0002153) | 1.73402506 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.99131968 |
| 2 | OBSCN | 3.97703526 |
| 3 | NTRK3 | 3.53209591 |
| 4 | MAP3K9 | 3.09261153 |
| 5 | MAP3K4 | 2.85306372 |
| 6 | MARK1 | 2.59511585 |
| 7 | MAP2K4 | 2.42450334 |
| 8 | DAPK2 | 2.22028502 |
| 9 | MINK1 | 2.15198839 |
| 10 | MAP3K10 | 2.12321060 |
| 11 | PAK6 | 2.04436110 |
| 12 | NTRK2 | 2.00408799 |
| 13 | MAP2K7 | 1.89717979 |
| 14 | KSR2 | 1.88474305 |
| 15 | EEF2K | 1.87365158 |
| 16 | BCKDK | 1.84463835 |
| 17 | PRKD3 | 1.83383112 |
| 18 | NTRK1 | 1.81022677 |
| 19 | CAMKK1 | 1.76551197 |
| 20 | LMTK2 | 1.55639319 |
| 21 | PHKG2 | 1.49185082 |
| 22 | PHKG1 | 1.49185082 |
| 23 | PINK1 | 1.48031497 |
| 24 | STK38 | 1.45035769 |
| 25 | CDK5 | 1.29946323 |
| 26 | SGK494 | 1.29382263 |
| 27 | SGK223 | 1.29382263 |
| 28 | MAPK11 | 1.26914191 |
| 29 | SIK1 | 1.25553263 |
| 30 | INSRR | 1.24032907 |
| 31 | KSR1 | 1.22836029 |
| 32 | RPS6KB1 | 1.22737626 |
| 33 | MAP3K2 | 1.22005076 |
| 34 | PAK3 | 1.21035606 |
| 35 | PRKCG | 1.18586445 |
| 36 | FGFR3 | 1.17647307 |
| 37 | OXSR1 | 1.16702954 |
| 38 | MAP2K6 | 1.15408301 |
| 39 | TRIB3 | 1.10697696 |
| 40 | SGK3 | 1.09162154 |
| 41 | TYRO3 | 1.08732966 |
| 42 | SGK2 | 1.07564873 |
| 43 | CAMK1G | 1.03238637 |
| 44 | RET | 1.02540843 |
| 45 | TNIK | 0.99548254 |
| 46 | PRKCH | 0.99335922 |
| 47 | WNK4 | 0.99176366 |
| 48 | LATS2 | 0.98351539 |
| 49 | DYRK1A | 0.97496043 |
| 50 | FGFR2 | 0.96679517 |
| 51 | NEK6 | 0.95698409 |
| 52 | CAMK2A | 0.95503787 |
| 53 | WNK3 | 0.95248281 |
| 54 | MAP3K13 | 0.93822989 |
| 55 | PIK3CA | 0.92483942 |
| 56 | UHMK1 | 0.92350142 |
| 57 | PDK4 | 0.92164045 |
| 58 | PDK3 | 0.92164045 |
| 59 | SCYL2 | 0.90132275 |
| 60 | GRK5 | 0.90074988 |
| 61 | STK11 | 0.89746111 |
| 62 | NEK1 | 0.89176874 |
| 63 | ERBB4 | 0.87133196 |
| 64 | MAP3K7 | 0.86575155 |
| 65 | PDPK1 | 0.86307628 |
| 66 | CAMKK2 | 0.81961387 |
| 67 | PRPF4B | 0.81061495 |
| 68 | CAMK2G | 0.80051673 |
| 69 | PNCK | 0.80050239 |
| 70 | STK39 | 0.79907107 |
| 71 | MAPK10 | 0.79436871 |
| 72 | CSNK1G2 | 0.79196069 |
| 73 | PKN1 | 0.78881125 |
| 74 | PKN2 | 0.78344099 |
| 75 | PRKCZ | 0.78299754 |
| 76 | RIPK1 | 0.77398516 |
| 77 | WNK1 | 0.77206708 |
| 78 | PDK1 | 0.76779000 |
| 79 | CAMK1 | 0.76334590 |
| 80 | TAOK1 | 0.76309273 |
| 81 | TNK2 | 0.75328599 |
| 82 | SIK2 | 0.75278488 |
| 83 | ARAF | 0.74778993 |
| 84 | DAPK1 | 0.74569046 |
| 85 | MAP3K12 | 0.74141900 |
| 86 | CAMK2B | 0.73383138 |
| 87 | ICK | 0.70703237 |
| 88 | CCNB1 | 0.70654256 |
| 89 | SGK1 | 0.66686480 |
| 90 | FES | 0.64530832 |
| 91 | CASK | 0.63702171 |
| 92 | CSNK1D | 0.63671177 |
| 93 | CAMK2D | 0.63465039 |
| 94 | MAP3K1 | 0.63201753 |
| 95 | MAPKAPK3 | 0.62456722 |
| 96 | CDK19 | 0.62341925 |
| 97 | CDK15 | 0.61501904 |
| 98 | CDC42BPA | 0.61443160 |
| 99 | RPS6KA3 | 0.61044137 |
| 100 | PLK2 | 0.60902888 |
| 101 | CDK14 | 0.59718835 |
| 102 | PRKAA2 | 0.59353781 |
| 103 | CDK18 | 0.59169038 |
| 104 | RAF1 | 0.58249129 |
| 105 | PRKAA1 | 0.57326467 |
| 106 | MAPK13 | 0.57005986 |
| 107 | CAMK4 | 0.56759883 |
| 108 | PRKACG | 0.55767105 |
| 109 | FGFR4 | 0.55205669 |
| 110 | CAMK1D | 0.51665636 |
| 111 | PIK3CG | 0.50387234 |
| 112 | ERN1 | 0.50026007 |
| 113 | PRKG1 | 0.49816521 |
| 114 | MAPK4 | 0.48786932 |
| 115 | CDK11A | 0.48097206 |
| 116 | MARK2 | 0.47704748 |
| 117 | FRK | 0.47111268 |
| 118 | EIF2AK1 | 0.46847140 |
| 119 | CDK4 | 0.46747983 |
| 120 | CSNK1E | 0.46218498 |
| 121 | FER | 0.45933058 |
| 122 | SYK | 0.45844572 |
| 123 | AKT2 | 0.45570518 |
| 124 | MAP2K1 | 0.45265877 |
| 125 | PRKCE | 0.45206811 |
| 126 | RIPK4 | 0.44531060 |
| 127 | ALK | 0.44327031 |
| 128 | MAPK12 | 0.44232270 |
| 129 | PRKACA | 0.43849462 |
| 130 | GSK3B | 0.42198436 |
| 131 | TTN | 0.40708948 |
| 132 | DYRK1B | 0.39534878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.56860332 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.01165661 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.00363258 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.63999306 |
| 5 | * Butanoate metabolism_Homo sapiens_hsa00650 | 2.21670289 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.19781683 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.09882379 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.06423884 |
| 9 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.94638313 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.94281968 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.93017166 |
| 12 | * Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.86308169 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.83469582 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.77905252 |
| 15 | Bile secretion_Homo sapiens_hsa04976 | 1.69631650 |
| 16 | Nicotine addiction_Homo sapiens_hsa05033 | 1.68449796 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.68144875 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68035421 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.62427492 |
| 20 | GABAergic synapse_Homo sapiens_hsa04727 | 1.61231072 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.49643285 |
| 22 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.42412367 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.42261491 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.32292182 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.30610501 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.29701157 |
| 27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.27515346 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.23677007 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22633403 |
| 30 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.16199754 |
| 31 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.15373995 |
| 32 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.14620756 |
| 33 | Circadian entrainment_Homo sapiens_hsa04713 | 1.14262141 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.09750410 |
| 35 | Morphine addiction_Homo sapiens_hsa05032 | 1.09285469 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08586360 |
| 37 | Olfactory transduction_Homo sapiens_hsa04740 | 1.08268949 |
| 38 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.08213138 |
| 39 | Insulin secretion_Homo sapiens_hsa04911 | 1.07630303 |
| 40 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.07470416 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.02076982 |
| 42 | Long-term potentiation_Homo sapiens_hsa04720 | 0.99349934 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 0.98295585 |
| 44 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.96245662 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 0.96102240 |
| 46 | Salivary secretion_Homo sapiens_hsa04970 | 0.95866047 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.93013612 |
| 48 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92986787 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.92718901 |
| 50 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.90864149 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89811958 |
| 52 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88086476 |
| 53 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.87693997 |
| 54 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.84895956 |
| 55 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.84491198 |
| 56 | Cocaine addiction_Homo sapiens_hsa05030 | 0.84027997 |
| 57 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.83920493 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.83375541 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82517610 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.78222135 |
| 61 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.75748506 |
| 62 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.75287499 |
| 63 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.71711818 |
| 64 | ABC transporters_Homo sapiens_hsa02010 | 0.70999975 |
| 65 | Renin secretion_Homo sapiens_hsa04924 | 0.70354345 |
| 66 | Retinol metabolism_Homo sapiens_hsa00830 | 0.69585700 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69500834 |
| 68 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.69280069 |
| 69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.69189807 |
| 70 | Taste transduction_Homo sapiens_hsa04742 | 0.67847150 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.67171771 |
| 72 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66448715 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66213760 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.65500369 |
| 75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.62280323 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61231984 |
| 77 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61201904 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60476242 |
| 79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.59502706 |
| 80 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.58740274 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58140451 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57610625 |
| 83 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.53703968 |
| 84 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.53506375 |
| 85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.52670983 |
| 86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.52322594 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51952275 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51543180 |
| 89 | Long-term depression_Homo sapiens_hsa04730 | 0.51418451 |
| 90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51156598 |
| 91 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49771924 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49522935 |
| 93 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48558724 |
| 94 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.48011149 |
| 95 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.47821799 |
| 96 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.47361602 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.46777649 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46769601 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.46223091 |
| 100 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.45957725 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.45734635 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.45565275 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43528711 |
| 104 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41759496 |
| 105 | Gap junction_Homo sapiens_hsa04540 | 0.41583621 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38632301 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37604412 |
| 108 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.37323709 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36830717 |
| 110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.34719897 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34219654 |
| 112 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.33384534 |
| 113 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.33111497 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.32189014 |

